According to the World Health Organization, as of January 22, 2025, more than 5,000 chikungunya virus disease (CHIKVD) cases and two deaths were reported across four countries worldwide. In 2024, a total of 620,000 cases and 213 deaths were documented, mostly in the Americas, with Brazil, Paraguay, and Argentina experiencing the highest infection rates. In Asia, India and Pakistan reported significant numbers of cases, while Senegal remained the only affected country in Africa. Europe recorded one locally transmitted case in France and 118 cases in La Réunion.

Key Market Trends & Insights

• North America accounted for 40.95% of global revenue in 2024, maintaining its position as the largest market.

• The U.S. infectious disease molecular diagnostics market is anticipated to experience strong growth throughout the forecast period.

• By application, the respiratory diseases segment held the highest market share at 71.96% in 2024.

• By product, the reagents segment led with 25.86% of revenue in 2024.

• By technology, PCR remained the dominant diagnostic method in 2024.

Market Size & Forecast

• 2024 Market Size: USD 16.24 Billion

• 2030 Projected Market Size: USD 20.15 Billion

• CAGR (2025–2030): 3.4%

• Largest Market (2024): North America

Key Infectious Disease Molecular Diagnostics Company Insights

The global market is highly competitive, with major players—including Danaher Corporation, Bio-Rad Laboratories, bioMérieux SA, and F. Hoffmann-La Roche Ltd—focusing on enhancing diagnostic speed, accuracy, specialization, and reliability. Their strategies include sustained R&D investment, new product development, and strategic mergers and acquisitions.

• Danaher Corporation is a multinational leader in life sciences and diagnostics, recognized for its Kaizen-oriented continuous improvement model. The company manufactures a wide range of medical and industrial products used across diagnostic and research settings.

• Bio-Rad Laboratories, Inc., headquartered in the U.S., is a major developer of life science research tools and clinical diagnostic systems. Its product portfolio includes instruments, software, reagents, consumables, and integrated scientific solutions used in applications such as gene expression, drug discovery, protein purification, and cell biology.

Leading Market Participants

• Abbott

• Danaher Corporation

• Bio-Rad Laboratories, Inc.

• bioMérieux SA

• F. Hoffmann-La Roche Ltd

• Agilent Technologies, Inc.

• Becton, Dickinson and Company

• Hologic, Inc. (Gen-Probe)

• Illumina, Inc.

• Grifols S.A.

• Qiagen

• Siemens Healthineers AG

• Sysmex Corporation

Order a free sample PDF of the Infectious Disease Molecular Diagnostics Market Intelligence Study, published by Grand View Research.